Physician profile
Brian A Link
NPI 1023167798
$6,669.33
in general payments reported to CMS, 2019-2025
47 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,366 · 2020: $529 · 2021: $671 · 2022: $962 · 2023: $595 · 2024: $593 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.49 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,878.66 | 2019-2020 | |
| Astellas Pharma US INC | $793.09 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $440.52 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Advance Xp |
| Medtronic, INC. | $279.11 | 2022-2025 | Interstim |
| Pfizer INC. | $274.74 | 2019-2025 | |
| Abbvie INC. | $249.36 | 2019-2025 | |
| Janssen Biotech, INC. | $240.83 | 2019-2022 | |
| Antares Pharma, INC. | $190.51 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Urogen Pharma, INC. | $189.71 | 2021-2025 | Jelmyto |
| Myovant Sciences INC. | $187.80 | 2021-2022 | |
| Biotissue Holdings INC. | $166.74 | 2025 | |
| Palette Life Sciences, INC. | $157.35 | 2022 | |
| Teleflex LLC | $107.66 | 2021-2025 | Urolift, Barrigel |
| Urovant Sciences INC | $91.09 | 2021-2022 | |
| Axonics, INC. | $84.82 | 2021-2023 | Axonics |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.